-
OncoMark acquired by US molecular diagnostic company, Cepheid Inc.
Trinity's Professor Adrian Bracken spearheaded the research that initially led to the identification of a panel of genetic drivers of breast cancer, and which gave rise to a novel cancer test developed by the company.
16 Dec 2021
Research
-
Severe-COVID patients risk an increase in mortality rate when cared for outside of an ICU
Study points to Ireland having one of the lowest numbers of ICU beds in Europe and prompts calls from critical care consultants for urgent investment in critical care beds
15 Dec 2021
Research
-
Two Trinity-AMBER research projects secure European Innovation Council funding in major Horizon Europe success
The two awards represent Trinity’s first successes in Horizon Europe, the EU’s key funding programme for research and innovation. They have a total recommended funding value of over €6 million, with around €2 million expected to go to the Trinity teams.
14 Dec 2021
Research
-
Vitamin B12 deficiency increases risk of depression: TILDA study
New research from ageing experts at Trinity College finds longitudinal associations between B12 deficiency and risk of depression, over four years.
14 Dec 2021
Research
-
From flashing fireflies to cheering crowds – physicists unlock secret to synchronisation
This new discovery has a suite of potential applications, including developing new types of computer technology that uses light signals to process information.
13 Dec 2021
Research